CUSIP: 09069N108
Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
65,772,003
-
Share change
-
-970,506
-
Total reported value
-
$486,723,566
-
Put/Call ratio
-
12%
-
Price per share
-
$7.40
-
Number of holders
-
133
-
Value change
-
-$7,181,161
-
Number of buys
-
3
-
Number of sells
-
2
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2014
-
Previous quarter:
Q3 2013
Recent filing periods for CUSIP 09069N108:
Institutional Holders of BIOSCRIP INC - COM (BIOS) as of Q4 2013
As of 31 Dec 2013,
BIOSCRIP INC - COM (BIOS) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,772,003 shares.
The largest 10 holders included
FMR LLC, Pennant Capital Management, LLC, GILDER GAGNON HOWE & CO LLC, Consonance Capital Management LP, VANGUARD GROUP INC, ROYAL BANK OF CANADA, DIMENSIONAL FUND ADVISORS LP, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., WHV Investment Management, Inc., and MILLENNIUM MANAGEMENT LLC.
This page lists
133
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.